Dihydrofolic reductase in human blood cells. II. Enzyme activity after amethopterin and actinomycin C administration.
D001773:Blood Cells / Q000187:drug effects* / Q000201:enzymology; D001853:Bone Marrow / Q000187:drug effects / Q000201:enzymology; D001854:Bone Marrow Cells; D003609:Dactinomycin / Q000494:pharmacology*; D003864:Depression, Chemical; D004790:Enzyme Induction; D004912:Erythrocytes / Q000187:drug effects / Q000201:enzymology; D006801:Humans; D007945:Leukemia, Lymphoid / Q000201:enzymology; D007951:Leukemia, Myeloid / Q000201:enzymology; D007962:Leukocytes / Q000187:drug effects / Q000201:enzymology; D008727:Methotrexate / Q000097:blood / Q000494:pharmacology*; D013268:Stimulation, Chemical; D013762:Tetrahydrofolate Dehydrogenase / Q000097:blood; D013997:Time Factors
D003609:Dactinomycin; D013762:Tetrahydrofolate Dehydrogenase; D008727:Methotrexate